Takeda's buying spree continues with CNS splurge

Deborah Weinstein

November 06 2012

Takeda is plunking down $140 million for Envoy Therapeutics and its CNS tech

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.